Propranolol for infantile hemangiomas

Global Advances In Health and Medicine

Volumn 1, Issue 2, 2012, Pages 14-16

  Levy, Moise L ^a  

^a DELL CHILDREN S MEDICAL CENTER OF CENTRAL TEXAS   (United States)

Author keywords

Arterial; Beta blocker; Cardiac; Corticosteroids; Eye anomalies; Hemangioma; Phace; Posterior fossa malformation; Propranolol; Segmental; Timolol; Vascular birthmarks

Indexed keywords

CORTICOSTEROID; PROPRANOLOL; TIMOLOL;

ARTICLE; CASE REPORT; CORPUS CALLOSUM AGENESIS; DRUG DOSE REDUCTION; DRUG RESPONSE; FEMALE; HEMANGIOMA; HUMAN; HYDROCEPHALUS; INFANT; LOW DRUG DOSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHACE SYNDROME; PRIORITY JOURNAL; SYNDROME;

EID: 84884302938     PISSN: 2164957X     EISSN: 21649561     Source Type: Journal    
DOI: 10.7453/gahmj.2012.1.2.004     Document Type: Article

References (14)

1. Alper JC, Holmes LB. The incidence and significance of birthmarks in a cohort of 4,641 newborns. Pediatr Dermatol. 1983;1(1):58-68.
2. Chang LC, Haggstrom AN, Drolet BA, et al. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics. 2008;122(2):360-7.
3. Haggstrom AN, Lammer EJ, Schneider RA, Marcucio R, Frieden IJ. Patterns of infantile hemangiomas: new clues to hemangioma pathophysiology and embryonic facial development. Pediatrics. 2006:117(3):698-703.
4. Metry DW, Haggstrom AN, Drolet BA. A prospective study of PHACE syndrome in infantile hemangiomas: demographic features, clinical findings, and complications. Am J Med Genet A. 2006;140(9):975-86.
5. Metry D, Heyer G, Hess C. Consensus statement on diagnostic criteria for PHACE syndrome. Pediatrics 2009;124(5):1447-56.
6. Fost NC, Esterly NB. Successful treatment of juvenile hemangiomas with prednisone. J Pediatr. 1968;72(3):351-7.
7. Frieden IJ, Eichenfield LF, Esterly NB, Geronemus R, Mallory SB. Guidelines for care of hemangiomas of infancy. American Academy of Dermatology Guidelines/Outcomes Committee. J Am Acad Dermatol. 1997;37(4):631-7.
8. Leaute-Labreze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358(24):2649-51.
9. Sans V, de la Roque ED, Berge J, et al. Propranolol for severe infantile hemangiomas: Follow-up report. Pediatrics. 2009;124(3):e423-31.
10. Hogeling M, de la Roque ED, Berge J, et al. A randomized controlled trial of propranolol for infantile hemangiomas. Pediatrics. 2011;128(2):e259-66.
11. Guo S, Ni N. Topical treatment for infantile hemangioma of the eyelid using beta-blocker solution. Arch Ophthal. 2010;128(2):255-6.
12. Pope E, Chakkittakandiyil A. Topical timolol gel for infantile hemangiomas: a pilot study. Arch Dermatol. 2010;146(5):564-5.
13. Hassanein AH, Mulliken JB, Fishman SJ, Greene AK. Evaluation of terminology for vascular anomalies in current literature. Plast Reconstr Surg. 2011;127(1):347-51.
14. Haggstrom AN, Garzon MC, Baselga E, et al. Risk for PHACE syndrome in infants with large facial hemangiomas. Pediatrics. 2010;126(2):e418-26.